69 related articles for article (PubMed ID: 3040319)
1. Heparin-binding angiogenesis factors: detection by immunological methods.
Wadzinski MG; Folkman J; Sasse J; Devey K; Ingber D; Klagsbrun M
Clin Physiol Biochem; 1987; 5(3-4):200-9. PubMed ID: 3040319
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer.
Chodak GW; Hospelhorn V; Judge SM; Mayforth R; Koeppen H; Sasse J
Cancer Res; 1988 Apr; 48(8):2083-8. PubMed ID: 3349479
[TBL] [Abstract][Full Text] [Related]
3. Multiple forms of an angiogenesis factor: basic fibroblast growth factor.
Moscatelli D; Joseph-Silverstein J; Presta M; Rifkin DB
Biochimie; 1988 Jan; 70(1):83-7. PubMed ID: 2840975
[TBL] [Abstract][Full Text] [Related]
4. Bovine pituitary heparin-binding fibroblast growth factors: acidic and basic forms.
Ho PL; Caron E; Armelin HA; Gambarini AG
Braz J Med Biol Res; 1988; 21(2):203-12. PubMed ID: 3203156
[TBL] [Abstract][Full Text] [Related]
5. Human tumor cells synthesize an endothelial cell growth factor that is structurally related to basic fibroblast growth factor.
Klagsbrun M; Sasse J; Sullivan R; Smith JA
Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2448-52. PubMed ID: 3458207
[TBL] [Abstract][Full Text] [Related]
6. The glycine box: a determinant of specificity for fibroblast growth factor.
Luo Y; Lu W; Mohamedali KA; Jang JH; Jones RB; Gabriel JL; Kan M; McKeehan WL
Biochemistry; 1998 Nov; 37(47):16506-15. PubMed ID: 9843417
[TBL] [Abstract][Full Text] [Related]
7. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
Wang P; Branch DR; Bali M; Schultz GA; Goss PE; Jin T
Biochem J; 2003 Oct; 375(Pt 1):199-205. PubMed ID: 12841847
[TBL] [Abstract][Full Text] [Related]
8. A panel of angiogenic factors for early bladder cancer detection: enzyme immunoassay and Western blot.
Eissa S; Swellam M; Labib RA; El-Zayat T; El Ahmady O
J Urol; 2009 Mar; 181(3):1353-60. PubMed ID: 19185322
[TBL] [Abstract][Full Text] [Related]
9. Presence of heparin binding growth factor in mouse bladder tumors and urine from mice with bladder cancer.
Chodak GW; Shing Y; Borge M; Judge SM; Klagsbrun M
Cancer Res; 1986 Nov; 46(11):5507-10. PubMed ID: 3756899
[TBL] [Abstract][Full Text] [Related]
10. Expression of fibroblast growth factor-5 by bovine choroidal endothelial cells in vitro.
Keithahn MA; Aotaki-Keen AE; Schneeberger SA; Hjelmeland LM; Morse LS
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2073-80. PubMed ID: 9331271
[TBL] [Abstract][Full Text] [Related]
11. High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF 8.
Tanaka A; Furuya A; Yamasaki M; Hanai N; Kuriki K; Kamiakito T; Kobayashi Y; Yoshida H; Koike M; Fukayama M
Cancer Res; 1998 May; 58(10):2053-6. PubMed ID: 9605740
[TBL] [Abstract][Full Text] [Related]
12. Keratinocyte growth factor and fibroblast growth factor action on DNA synthesis in rat and human hepatocytes: modulation by heparin.
Strain AJ; McGuinness G; Rubin JS; Aaronson SA
Exp Cell Res; 1994 Feb; 210(2):253-9. PubMed ID: 7507851
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-I domain.
Hamma-Kourbali Y; Bernard-Pierrot I; Heroult M; Dalle S; Caruelle D; Milhiet PE; Fernig DG; Delbé J; Courty J
J Cell Physiol; 2008 Jan; 214(1):250-9. PubMed ID: 17607711
[TBL] [Abstract][Full Text] [Related]
14. Activity of tumor angiogenesis factor obtained from ovarian carcinoma cell line and its purification.
Ishiwata I; Ishiwata C; Ishikawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Oct; 38(10):1783-4. PubMed ID: 2431081
[No Abstract] [Full Text] [Related]
15. [Functions of heparin binding growth factor (HBGF or FGF) produced by tumor cells].
Nishikawa K; Yoshitake Y; Minemura M; Yamada K
Tanpakushitsu Kakusan Koso; 1991 May; 36(7):1364-70. PubMed ID: 1871358
[No Abstract] [Full Text] [Related]
16. Nucleosomes bind fibroblast growth factor-2 for increased angiogenesis in vitro and in vivo.
Tanner JE; Forté A; Panchal C
Mol Cancer Res; 2004 May; 2(5):281-8. PubMed ID: 15192121
[TBL] [Abstract][Full Text] [Related]
17. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization.
Ishihara M; Obara K; Ishizuka T; Fujita M; Sato M; Masuoka K; Saito Y; Yura H; Matsui T; Hattori H; Kikuchi M; Kurita A
J Biomed Mater Res A; 2003 Mar; 64(3):551-9. PubMed ID: 12579570
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor.
Mise M; Arii S; Higashituji H; Furutani M; Niwano M; Harada T; Ishigami S; Toda Y; Nakayama H; Fukumoto M; Fujita J; Imamura M
Hepatology; 1996 Mar; 23(3):455-64. PubMed ID: 8617424
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a heparin-binding growth factor from adenocarcinoma of the kidney.
Mydlo JH; Heston WD; Fair WR
J Urol; 1988 Dec; 140(6):1575-9. PubMed ID: 3193547
[TBL] [Abstract][Full Text] [Related]
20. [The nature of angiogenic factors (review of the literature)].
Lisniak IA
Vopr Med Khim; 1990; 36(1):2-7. PubMed ID: 2188425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
